Xact
Payments companies reported to CMS as associated with Xact. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Xact, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Xact
These are the largest totals companies reported as associated with Xact. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Peter Faries | New York, NY | Vascular Surgery | $32,409.60 |
| Malcolm Foster | Knoxville, TN | Interventional Cardiology | $29,012.55 |
| Prakash Krishnan | New York, NY | Interventional Cardiology | $13,300.00 |
| Peter Schneider | Honolulu, HI | Vascular Surgery | $9,432.12 |
| Sean Lyden | Cleveland, OH | Vascular Surgery | $8,363.96 |
| David Metzger | Kingsport, TN | Cardiovascular Disease | $6,472.26 |
| David Kandzari | Atlanta, GA | Interventional Cardiology | $4,075.33 |
| Oluwakunle Oluwatosin | Osage Beach, MO | Interventional Cardiology | $4,003.03 |
| James Yhip | Amarillo, TX | Cardiovascular Disease | $3,795.85 |
| Brajesh Lal | Baltimore, MD | Vascular Surgery | $3,609.77 |
Prescribed Xact?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.